FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
Watch CBS News
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Mr. Trump announced a deal with two pharmaceutical companies to reduce the cost of popular medicines, including Wegovy and Zepbound. CBS News New York's Gwen Baumgardner has the details.
Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.
The FDA says the nationwide shortage for Ozempic and Wegovy is over, but as CBS News New York's Ali Bauman explains, that supply change could lead to consumers paying more.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.
Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread. CBS News New York's Lisa Rozner reports.
Millions of Americans have turned to popular prescription medications to treat diabetes and lose weight, but some say the drugs can have serious negative health effects. CBS News senior investigative consumer correspondent Anna Werner has been looking into this.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Dr. Jayne Morgan joins CBS New York to discuss how GLP-1 medications like Ozempic can prevent cancer.
CBS New York's Jessica Moore looks into the widespread impact of these life-changing medications.
Diabetes drugs like Ozempic have gained popularity for weight loss, but a New York City Council member is hoping to raise more awareness about side effects with a new bill.
A new study from drugmaker Novo Nordisk found that its weight-loss drug Wegovy can reduce the risk of heart problems in people without diabetes, which could change the way doctors treat certain heart patients.
